Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease

The aims of this study were to investigate risk factors for cognitive and functional decline among 193 patients with Alzheimer’s disease dementia (AD), and to conduct pharmacogenetic analysis on cerebrovascular metabolism modulators, taking into account APOE haplotypes and the genotypes of ACE, CETP...

Full description

Bibliographic Details
Main Author: Fabricio Ferreira de Oliveira
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2015-03-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000300259&lng=en&tlng=en